4//SEC Filing
Durenard Eugene 4
Accession 0001562180-24-004431
CIK 0001692415other
Filed
May 27, 8:00 PM ET
Accepted
May 28, 4:01 PM ET
Size
7.6 KB
Accession
0001562180-24-004431
Insider Transaction Report
Form 4
Durenard Eugene
Director
Transactions
- Exercise/Conversion
Restricted Stock Unit
2024-05-23−30,000→ 200,000 totalExercise: $0.00→ Common Stock (230,000 underlying) - Award
Common Stock
2024-05-23+30,000→ 115,000 total
Footnotes (1)
- [F1]Included in 70,000 restricted stock units awarded to the Reporting Person on July 7, 2022, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in six equal installments every six months commencing on November 23, 2022. Included in 40,000 restricted stock units awarded to the Reporting Person on January 17, 2023, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in six equal installments every six months commencing on May 23, 2023. Included in 70,000 restricted stock units awarded to the Reporting Person on June 12, 2023, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in six equal installments every six months commencing on November 23, 2023.
Documents
Issuer
Co-Diagnostics, Inc.
CIK 0001692415
Entity typeother
Related Parties
1- filerCIK 0001812942
Filing Metadata
- Form type
- 4
- Filed
- May 27, 8:00 PM ET
- Accepted
- May 28, 4:01 PM ET
- Size
- 7.6 KB